Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluation of Ranibizumab in Proliferative Diabetic Retinopathy (PDR) Requiring Vitrectomy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2007 by Retina Associates, Kansas City.
Recruitment status was  Recruiting
Genentech, Inc.
Information provided by:
Retina Associates, Kansas City Identifier:
First received: August 14, 2007
Last updated: NA
Last verified: August 2007
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2008
  Estimated Primary Completion Date: No date given